Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism.

Annals of hematology - 1 Feb 2021

Serin Istemi, Pehlivan Sacide, Gundes Ilknur, Fidan Oyaci Yasemin, Pehlivan Mustafa

Abstract excerpt

Multiple myeloma (MM) is a disease caused by malignant plasma cells, causing free light chain release accompanying the increase in monoclonal immunoglobulin. Cytochrome P450 (CYP) is one of the large and functional enzyme families composed of various hemoproteins. This protein network has been shown to play a role in many treatment steps in current practices. We aimed to investigate the relationship between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytochrome P-450 CYP3A
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Myeloma

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 33170343
DOI: 10.1007/s00277-020-04339-1
PMCID: PMC7653211

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism.PMID 33170343Read ↗

CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma.Semantic proximity Read ↗

Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.Semantic proximity Read ↗

Effect of CYP2C19 polymorphism on response to bortezomib-based therapy in multiple myeloma patients.Semantic proximity Read ↗

Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters and survival of multiple myeloma cases in a Polish populationSemantic proximity Read ↗

Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes.Semantic proximity Read ↗

Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.Semantic proximity Read ↗

Genetic polymorphisms and multiple myeloma risk: a meta-analysis.Semantic proximity Read ↗

Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma.Semantic proximity Read ↗

Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population.Semantic proximity Read ↗

Polymorphisms contribution to the determination of significant risk of specific toxicities in multiple myeloma.Semantic proximity Read ↗

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.Semantic proximity Read ↗

Genetic variations in multiple myeloma II: association with effect of treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.